Clinical trial
Gubbio Study Five-year Follow-up: Lithium Countertransport, Blood Pressure, and…
NCT00005232 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00005232 |
|---|---|
| Title | Gubbio Study Five-year Follow-up: Lithium Countertransport, Blood Pressure, and Other Variables |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Collaborators | Merck Sharp & Dohme LLC Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Cardiovascular Diseases, Heart Diseases, Hypertension, Coronary Disease |
| Start date | Aug 1, 1988 |
| Completion | Jul 1, 1993 |
| First posted | May 26, 2000 |
| Last update posted | Mar 16, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: